RT Journal Article
T1 The impact of COVID-19 on DTP3 vaccination coverage in Europe (2012–2023)
A1 Aguinaga Ontoso, Inés
A1 Guillen Aguinaga, Sara
A1 Guillen Aguinaga, Laura
A1 Alas Brun, Rosa
A1 Guillen Aguinaga, Miriam
A1 Onambele, Luc
A1 Aguinaga Ontoso, Enrique
A1 Rayón Valpuesta, Esperanza
A1 Guillen Grima, Francisco
AB Background: The COVID-19 pandemic disrupted routine child immunization efforts, threatening to reverse progress in controlling vaccine-preventable diseases. Materials and Methods: We analyzed the impact of COVID-19 on DTP3 vaccination in Europe by comparing trends before and after the pandemic using time series data from 2000 to 2023. Employing joinpoint regression, chi-square tests, and segmented regression analysis, we assessed DTP3 vaccination trends and coverage changes. Results: The findings revealed significant regional disparities across Europe. Statistical models indicated reductions in DTP3 coverage in countries such as Ireland, Sweden, and Switzerland, whereas Ukraine and San Marino showed improvements. Conclusions: There are variations in the effect of COVID-19 on DTP3 coverage rates, indicating the need for targeted public health strategies to address vaccine hesitancy, logistical barriers, and systemic inequities.
PB MDPI
YR 2024
FD 2024-12-24
LK https://hdl.handle.net/20.500.14352/130760
UL https://hdl.handle.net/20.500.14352/130760
LA eng
NO Aguinaga-Ontoso, I.; Guillen-Aguinaga, S.; Guillen-Aguinaga, L.; Alas-Brun, R.; Guillen-Aguinaga, M.; Onambele, L.; Aguinaga-Ontoso, E.; Rayón-Valpuesta, E.; Guillen-Grima, F. The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023). Vaccines 2025, 13, 6. https://doi.org/10.3390/vaccines13010006
DS Docta Complutense
RD 17 mar 2026